Marisa Calabuig

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

Journal: Blood advances

Published: January 20, 2026

Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Journal: Cancers

Published: April 25, 2025

Rapid Screening and Monitoring of UBA1 Mutations in VEXAS Syndrome.

Rapid Screening and Monitoring of UBA1 Mutations in VEXAS Syndrome.

Journal: The Journal of molecular diagnostics : JMD

Published: September 21, 2024

Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms.

Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms.

Journal: British journal of haematology

Published: March 05, 2024

EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome.

EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: December 17, 2023

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.

Journal: Therapeutic advances in hematology

Published: March 23, 2023

Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.

Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.

Journal: Haematologica

Published: February 12, 2023

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.

Journal: Blood cancer journal

Published: November 09, 2022

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients.

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients.

Journal: Annals of hematology

Published: February 19, 2022

Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.

Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.

Journal: Therapeutic advances in hematology

Published: January 16, 2022

Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria.

Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria.

Journal: Leukemia research

Published: November 01, 2021

Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19.

Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19.

Journal: Blood advances

Published: October 13, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026